Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 41030 - orthosis, spinal, lumbosacral, pendulous abdomen support - designed to support a pregnant women's growing belly, correct posture and help prevent back pain during pregnancy, and help with postnatal recovery after childbirth. ergonomic design to follow the contours of a pregnant body as well as a body post birth. designed to stay in place throughout the day. soft touch material, gentle on the skin and won?t hinder their natural movements. premium, durable elastic, easy to put on and adjust. four elastic sub-belts to lift up/tighten the belly and support the back. can be worn discreetly under clothes with minimum show through.

Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 41030 - orthosis, spinal, lumbosacral, pendulous abdomen support - purpose of this device is to support a women's uterus, abdomen, pelvis, back and spine during pregnancy and assist with the relieve of pressure points and eases sciatic, back & pelvic pain. it achieves this by lifting the pregnant belly like pair of hands and sharing some of that newly established weight around a wide area of back muscles and spine. this helps with back pain, improve blood circulation, bladder frequency, pelvic pain and swelling of the legs. can also be used to stabilise the user's core area, help with posture and correct their centre of gravity. this device has an ergonomic bump support moulds to the user's body and won't slip off, dig or roll. ultra-thin design so the user can wear it discreetly under clothing, breathable materials that won't trap heat or irritate. one device covers a wide range of sizes, so the user can buy it early in the pregnancy before the pain and discomfort develops, and keep on wearing. it also contains papolis (wahoo fish oil fibers) to moisturise and hydrate the s

Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 45606 - compression garment - a compression garment designed for postnatal recovery, by offering abdominal, back, pelvis and lower body support without inhibiting movement. comfortable, breathable and easy to move in, while the ultra lightweight fabric keeps the user cool and dry. extra high waist design supports the back and flattens the abdomen. high strength lifting panels gives more control to shape the thighs and lift the hips for instant support and shaping.

Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 45606 - compression garment - a compression garment designed for postnatal recovery, by offering abdominal and upper body support without inhibiting appetite or breast milk production. this body shaper top with a built-in breastfeeding crossover bra made with meryl anti-bacterial fabric allows the user to breastfeed easily by simply pulling down. this shaper top is long enough to cover the hips, and comfortable enough to sleep in with no itchy or rigid seams.

Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 45606 - compression garment - a compression garment designed for postnatal recovery, by offering comfortable abdominal and upper body support without inhibiting appetite or breast milk production. this body shaper singlet top nestles neatly under the bust, giving a touch of lift and allowing the user to breastfeed easily. long enough to cover the hips, and comfortable enough to sleep in with no itchy or rigid seams.

Australia - English - Department of Health (Therapeutic Goods Administration)

grandios pty ltd - 45606 - compression garment - purpose of this device is to support a women's uterus, abdomen, pelvis, back and spine after child birth. it achieves this by applying compression on the pelvic/ abdominal area to hold the expanded uterus wall, loose skin and muscles, and assist in the user's recovery in the core area. can also be used to stabilise the user's abdominal area or as back support while breastfeeding or carrying their baby. the product is antibacterial and contains 20% bamboo charcoal which naturally emits far-infrared radiation to boost blood circulation. fully adjustable velcro closure allows the user to fully control the tightness of the product by allowing the velcro to stick anywhere on the belt.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ziprasidone hydrochloride, quantity: 87.2 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; sucrose; titanium dioxide; indigo carmine; ammonium chloride; sodium starch glycollate type b; lactose monohydrate; gelatin; macrogol 6000; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - ziprasidone is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy. ziprasidone is indicated as monotherapy for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ziprasidone hydrochloride, quantity: 65.4 mg - capsule, hard - excipient ingredients: sodium starch glycollate type b; titanium dioxide; sucrose; macrogol 6000; indigo carmine; gelatin; sodium lauryl sulfate; ammonium chloride; purified water; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - ziprasidone is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy. ziprasidone is indicated as monotherapy for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ziprasidone hydrochloride, quantity: 43.6 mg - capsule, hard - excipient ingredients: macrogol 6000; ammonium chloride; lactose monohydrate; purified water; titanium dioxide; sucrose; gelatin; sodium starch glycollate type b; sodium lauryl sulfate; indigo carmine; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - ziprasidone is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy. ziprasidone is indicated as monotherapy for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ziprasidone hydrochloride, quantity: 21.8 mg - capsule, hard - excipient ingredients: gelatin; lactose monohydrate; sodium starch glycollate type b; purified water; sucrose; titanium dioxide; ammonium chloride; sodium lauryl sulfate; indigo carmine; macrogol 6000; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - ziprasidone is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy. ziprasidone is indicated as monotherapy for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder.